obsessive-compulsive%20disorder
OBSESSIVE-COMPULSIVE DISORDER
Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.

Multidisciplinary Review

Multidisciplinary Team

  • With expertise in obsessive-compulsive disorder & referred to when treatment options fail to produce adequate response
  • Supports & collaborates with those professionals already involved in the patient’s care

Recommendations after Multidisciplinary Review

  • Combination therapy with cognitive-behavioral therapy & selective serotonin reuptake inhibitors for patients with inadequate response to selective serotonin reuptake inhibitors alone within 12 weeks or cognitive-behavioral therapy of >10 therapist hours per patient
  • Another selective serotonin reuptake inhibitors or Clomipramine should be offered for patients with inadequate response to combined treatment of selective serotonin reuptake inhibitors & cognitive-behavioral therapy, no response to selective serotonin reuptake inhibitor alone, or have not engaged with cognitive-behavioral therapy
  • Clomipramine should be considered after an adequate trial of at least one selective serotonin reuptake inhibitor which has been ineffective or poorly tolerated, patient prefers Clomipramine, or has good response previously to Clomipramine
  • Other options if there are no response after a full trial of at least 1 selective serotonin reuptake inhibitor alone, combination therapy with cognitive-behavioral therapy & selective serotonin reuptake inhibitor, & Clomipramine alone
    • Additional cognitive-behavioral therapy
    • Additional antipsychotic to a selective serotonin reuptake inhibitor or Clomipramine
    • Combine Clomipramine & Citalopram

Monitoring

  • Frequency of visits will depend on the severity of the symptoms, complexities of co-occurring conditions, presence of suicidal ideation, & side effects
  • Psychotherapy should be done as often as necessary

Follow Up

  • Follow-up visit is done a few days to 2 weeks after the initiation of therapy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 17 Jan 2018

A recent study by The Hong Kong Polytechnic University has identified insufficient services and accommodation, non-standardized cognitive screening and lack of intervention to delay cognitive and health deterioration as issues faced by ageing patients with intellectual disability in Hong Kong. 

27 Dec 2017
Persistent symptoms, comorbidities, and financial challenges appear to be important factors affecting health-related quality of life (HRQOL) in geriatric cancer patients, a recent study has shown.
4 days ago
Patients with rare cancers have worse psychosocial and quality of life outcomes compared with the general population of cancer patients, a recent study has shown.